Literature DB >> 18355896

Cutaneous manifestations of vasculitis.

Lisa Y Xu1, Edward M Esparza, Milan J Anadkat, Kimberley G Crone, Richard D Brasington.   

Abstract

OBJECTIVES: To discuss the clinical features, diagnostic evaluation, and treatment options for cutaneous vasculitis.
METHODS: The literature in the PubMed database was reviewed regarding the presentation, pathophysiology, clinical workup, and treatment of cutaneous vasculitis.
RESULTS: Available classification criteria of vasculitis are based on histopathologic criteria or clinicohistologic features. These have been designed more for research purposes than for clinical application. Skin findings such as palpable purpura, nodules, urticaria, ulcers, and infarction are clues to the presence of vasculitis. Pathologic findings of fibrinoid necrosis, infiltration by neutrophils or lymphocytes, and deposition of complement and immunoglobulin may be helpful in reaching a specific diagnosis. However, there is considerable overlap across different conditions.
CONCLUSIONS: The correct diagnosis of cutaneous manifestations of vasculitis requires an understanding of vasculitis classification, recognition of specific clinical patterns, and the ability to interpret histopathologic data.

Entities:  

Mesh:

Year:  2008        PMID: 18355896     DOI: 10.1016/j.semarthrit.2008.01.007

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  3 in total

1.  Cocaine-induced vasculitis: is this a new trend?

Authors:  Miraida Reneé García Pérez; Vanessa L Ortiz-González; Maria Betancourt; Rogelio Mercado
Journal:  Open Access Rheumatol       Date:  2013-10-03

Review 2.  Arthropathy in Dermatology: A Comprehensive Review.

Authors:  Soumya Jagadeesan; Padmanabha Shenoy
Journal:  Indian Dermatol Online J       Date:  2017 Mar-Apr

3.  Henoch-Schonlein purpura presenting sequentially as nodular rash, erythema nodosum, and palpable purpura.

Authors:  Kandan Balamurugesan; Stalin Viswanathan
Journal:  J Family Community Med       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.